Humacyte (HUMA) News Today $1.58 +0.04 (+2.27%) As of 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HUMA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Humacyte (NASDAQ:HUMA) CEO Laura Niklason Sells 591,685 SharesAugust 21 at 7:45 AM | insidertrades.com1,049,828 Shares in Humacyte, Inc. $HUMA Acquired by Maven Securities LTDAugust 21 at 5:38 AM | marketbeat.comWall Street Zen Downgrades Humacyte (NASDAQ:HUMA) to SellAugust 19 at 2:47 AM | americanbankingnews.comHumacyte (NASDAQ:HUMA) Downgraded by Wall Street Zen to "Sell"August 18, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for Humacyte Q3 Earnings?August 16, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Humacyte Q3 Earnings?August 16, 2025 | americanbankingnews.comFY2029 EPS Estimates for Humacyte Cut by HC WainwrightAugust 15, 2025 | marketbeat.comHumacyte (NASDAQ:HUMA) Price Target Cut to $3.50 by Analysts at TD CowenAugust 14, 2025 | americanbankingnews.comHC Wainwright Cuts Humacyte (NASDAQ:HUMA) Price Target to $3.00August 14, 2025 | americanbankingnews.comTD Cowen Cuts Humacyte (NASDAQ:HUMA) Price Target to $3.50August 13, 2025 | marketbeat.comHumacyte (NASDAQ:HUMA) Price Target Cut to $3.00 by Analysts at HC WainwrightAugust 13, 2025 | marketbeat.comHumacyte’s Earnings Call: Progress Amid ChallengesAugust 13, 2025 | msn.comHumacyte Inc. (HUMA) Stock Price Today - WSJAugust 12, 2025 | wsj.comDurham biotech sees stock plunge on slow salesAugust 12, 2025 | bizjournals.comHumacyte, Inc. (NASDAQ:HUMA) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | msn.comHumacyte: Cash Burn And A Glacial Launch Overshadow VAC ProgressAugust 12, 2025 | seekingalpha.comD. Boral Capital Reaffirms "Buy" Rating for Humacyte (NASDAQ:HUMA)August 12, 2025 | marketbeat.comHumacyte (NASDAQ:HUMA) Posts Earnings Results, Misses Estimates By $0.09 EPSAugust 12, 2025 | marketbeat.comHumacyte Shares Drop After Wider-Than-Expected 2Q LossAugust 12, 2025 | marketwatch.comHumacyte targets over 200 hospital access points for Symvess as VAC approvals surge and cost cuts extend cash runwayAugust 12, 2025 | msn.comHumacyte, Inc. (HUMA) Q2 2025 Earnings Call TranscriptAugust 11, 2025 | seekingalpha.comHumacyte Announces Second Quarter 2025 Financial Results and Provides Business UpdateAugust 11, 2025 | globenewswire.comHumacyte (NASDAQ:HUMA) Upgraded to Hold at Wall Street ZenAugust 10, 2025 | marketbeat.comAn Overview of Humacyte's EarningsAugust 8, 2025 | benzinga.comCenterBook Partners LP Has $2.43 Million Holdings in Humacyte, Inc. (NASDAQ:HUMA)August 8, 2025 | marketbeat.comHumacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025August 7, 2025 | globenewswire.comHumacyte (HUMA) Expected to Announce Quarterly Earnings on TuesdayAugust 6, 2025 | marketbeat.com200,000 Shares in Humacyte, Inc. (NASDAQ:HUMA) Bought by Pamalican Asset Management LtdAugust 3, 2025 | marketbeat.comHumacyte, Inc. (NASDAQ:HUMA) Given Consensus Rating of "Buy" by AnalystsAugust 1, 2025 | marketbeat.comHumacyte stock rises after first Symvess sale to US Military facilityJuly 25, 2025 | investing.comHumacyte shares climb 6% after first Symvess sale to U.S. military hospitalJuly 25, 2025 | msn.comHumacyte (NASDAQ:HUMA) Given "Buy" Rating at D. Boral CapitalJuly 24, 2025 | marketbeat.comHumacyte Announces First Symvess™ Sale to Military Treatment FacilityJuly 23, 2025 | globenewswire.comHumacyte (NASDAQ:HUMA) Rating Lowered to Sell at Wall Street ZenJuly 19, 2025 | marketbeat.comHumacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should KnowJuly 18, 2025 | msn.comWhy Humacyte, Inc. (HUMA) Dipped More Than Broader Market TodayJuly 15, 2025 | msn.comHumacyte Shares Climb on Symvess ECAT Listing - MorningstarJuly 10, 2025 | morningstar.comMD. Boral Capital Reaffirms Buy Rating for Humacyte (NASDAQ:HUMA)July 9, 2025 | marketbeat.comHumacyte jumps as DoD issues ECAT listing approval for SymvessJuly 9, 2025 | msn.comHumacyte stock soars after Symvess gains DOD electronic catalog listingJuly 8, 2025 | in.investing.comHumacyte Shares Climb on Symvess ECAT ListingJuly 8, 2025 | marketwatch.comHumacyte announces Symvess™ ECAT Approval from U.S. Defense Logistics AgencyJuly 8, 2025 | globenewswire.comBeat the Market the Zacks Way: Humacyte, Starbucks, Oracle in FocusJuly 7, 2025 | msn.comHumacyte (NASDAQ:HUMA) Stock Rating Upgraded by Wall Street ZenJune 27, 2025 | marketbeat.comHumacyte, Inc. (HUMA) Stock Moves -1.79%: What You Should KnowJune 26, 2025 | msn.comHumacyte, Inc. (HUMA) Gains As Market Dips: What You Should KnowJune 18, 2025 | msn.comHumacyte (NASDAQ:HUMA) Downgraded by Wall Street Zen to SellJune 14, 2025 | marketbeat.comHumacyte: Revenue Ramp From Symvess IncomingJune 11, 2025 | seekingalpha.comCantor Fitzgerald Predicts Humacyte FY2026 EarningsJune 10, 2025 | marketbeat.comResults from Humacyte’s V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery MeetingJune 9, 2025 | theglobeandmail.com Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address HUMA Media Mentions By Week HUMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUMA News Sentiment▼-0.510.54▲Average Medical News Sentiment HUMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUMA Articles This Week▼138▲HUMA Articles Average Week Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RCUS News Today LENZ News Today VALN News Today SYRE News Today MLYS News Today STOK News Today NUVB News Today VERV News Today PRAX News Today CRMD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HUMA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access